AIM
SGMO

Aigen Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Aigen Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,577
Closed -$62K – 742
2022
Q3 		$62K Buy
+12,577
New +$64.6K 0.01% 559
2022
Q1 		– Sell
-13,661
Closed -$113K – 1013
2021
Q4 		$113K Buy
+13,661
New +$119K 0.01% 986
2020
Q4 		– Sell
-34,289
Closed -$324K – 1015
2020
Q3 		$324K Buy
+34,289
New +$371K 0.04% 512

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aigen Investment Management's SGMO Position: Q4 2022 in Review

Aigen Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 12,577 shares — an estimated $62K sold.

Aigen Investment Management first reported a position in SGMO in Q3 2020 and held it in 3 quarters. The position peaked at $324K in Q3 2020. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • Aigen Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Aigen Investment Management sold 12,577 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $62K.
  • Aigen Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2020 and held it in 3 quarters.
  • Aigen Investment Management's SANGAMO THERAPEUTICS INC position peaked at $324K in Q3 2020.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Aigen Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.